Literature DB >> 6236912

Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up.

A Gallino, F Mahler, P Probst, B Nachbur.   

Abstract

A total of 482 percutaneous transluminal angioplasties (PTAs) of the arteries of the lower limbs were performed in 411 patients between 1977 and 1983. The 5 year patency rate, calculated by the life table method, was 83% for iliac and 58% for femoropopliteal PTA. Clinical improvement after the procedure was confirmed by a significant drop of the arm-ankle pressure difference: 48 +/- 5 mm Hg before vs 17 +/- 5 mm Hg 2 years after iliac PTA (p less than .01) and 73 +/- 5 mm Hg before vs 28 +/- 6 mm Hg after femoropopliteal PTA (p less than .01). The majority of reocclusions occurred within the first year after angioplasty. Patients with stenoses or occlusions of less than 3 cm had a favorable long-term patency rate of 74%. Conversely, patients with femoropopliteal occlusions presenting with pain at rest, diabetes, occlusions of greater than 3 cm, or poor distal runoff had an elevated rate of reocclusion. Complications, which occurred in 8% of the patients in whom PTA was attempted, included local hemorrhage, dissection, embolism, and spasm necessitating surgical intervention in 2%. No deaths or amputations were a direct consequence of PTA. PTA of arteries of the lower limbs may thus be regarded as a valid complementary treatment to vascular surgery in patients with occlusive disease of the peripheral arteries.

Entities:  

Mesh:

Year:  1984        PMID: 6236912     DOI: 10.1161/01.cir.70.4.619

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions.

Authors:  J Triller; B H Walpoth; P Stirnemann; F Mahler
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

2.  Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial.

Authors:  J C Palmaz; J C Laborde; F J Rivera; C E Encarnacion; J D Lutz; J G Moss
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

3.  Long-term results of combined iliac balloon angioplasty and distal surgical revascularization.

Authors:  D C Brewster; R P Cambria; R C Darling; C A Athanasoulis; A C Waltman; S C Geller; A C Moncure; G M Lamuraglia; M Freehan; W M Abbott
Journal:  Ann Surg       Date:  1989-09       Impact factor: 12.969

4.  Segmentally enclosed thrombolysis in percutaneous transluminal angioplasty for femoropopliteal occlusions: a report from a pilot study.

Authors:  B Jørgensen; K H Tønnesen; J D Nielsen; P Holstein; J Bülow; M Jørgensen; E Andersen
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Sep-Oct       Impact factor: 2.740

5.  Late hemodynamic failure following percutaneous transluminal angioplasty for long and multifocal femoropopliteal stenoses.

Authors:  B Jørgensen; K H Tønnesen; P Holstein
Journal:  Cardiovasc Intervent Radiol       Date:  1991 Sep-Oct       Impact factor: 2.740

Review 6.  Antithrombotic treatment before and after peripheral artery percutaneous angioplasty.

Authors:  Adriana Visonà; Diego Tonello; Beniamino Zalunardo; Sandro Irsara; Guido Liessi; Lucia Marigo; Laura Zotta
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

7.  Outcome of femoropopliteal angioplasty.

Authors:  J Golledge; K Ferguson; M Ellis; T Sabharwal; A H Davies; R M Greenhalgh; J T Powell
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

Review 8.  Aortic-iliac occlusive disease.

Authors:  D Charlesworth
Journal:  World J Surg       Date:  1988-12       Impact factor: 3.352

Review 9.  An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors.

Authors:  Nicolas W Shammas
Journal:  Int J Angiol       Date:  2013-03

10.  Percutaneous transluminal aortic angioplasty: early and late results.

Authors:  B Morag; A Garniek; A Bass; J Schneiderman; R Walden; Z J Rubinstein
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Jan-Feb       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.